7.83
6.97%
0.51
Dopo l'orario di chiusura:
7.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.32
Aprire:
$7.41
Volume 24 ore:
6.80M
Relative Volume:
1.08
Capitalizzazione di mercato:
$1.24B
Reddito:
$793.74M
Utile/perdita netta:
$-398.71M
Rapporto P/E:
-1.0785
EPS:
-7.26
Flusso di cassa netto:
$-514.43M
1 W Prestazione:
-13.10%
1M Prestazione:
-23.08%
6M Prestazione:
-39.82%
1 anno Prestazione:
+36.65%
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Confronta NVAX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
NVAX | 7.83 | 1.24B | 793.74M | -398.71M | -514.43M | -7.26 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
2023-01-09 | Reiterato | B. Riley Securities | Buy |
2022-12-30 | Reiterato | H.C. Wainwright | Buy |
2022-12-02 | Iniziato | Jefferies | Hold |
2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
2022-05-20 | Iniziato | BofA Securities | Underperform |
2022-02-23 | Reiterato | B. Riley Securities | Buy |
2022-02-22 | Ripresa | Jefferies | Buy |
2022-01-21 | Iniziato | Cowen | Outperform |
2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
2020-12-14 | Iniziato | Jefferies | Buy |
2020-08-06 | Reiterato | H.C. Wainwright | Buy |
2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
2020-07-16 | Reiterato | H.C. Wainwright | Buy |
2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2020-06-29 | Reiterato | B. Riley FBR | Buy |
2020-06-29 | Reiterato | H.C. Wainwright | Buy |
2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
2020-05-28 | Reiterato | B. Riley FBR | Buy |
2020-05-12 | Reiterato | H.C. Wainwright | Buy |
2020-04-30 | Reiterato | H.C. Wainwright | Buy |
2019-11-27 | Ripresa | B. Riley FBR | Buy |
2019-08-14 | Reiterato | H.C. Wainwright | Buy |
2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
2018-12-11 | Iniziato | Oppenheimer | Outperform |
2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
How To Trade (NVAX) - Stock Traders Daily
HC Wainwright Brokers Reduce Earnings Estimates for Novavax - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
UK regulator approves adapted Novavax jab - The Pharma Letter
Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post
Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance
Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com
Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com
Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Stock Market Increases While Tesla And Novavax Take A Hit - Finimize
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - Yahoo Finance
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks
Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Novavax Becomes Oversold (NVAX) - Nasdaq
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals [Video] - AOL
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better - The Business Journals
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals - Yahoo Finance
Novavax to Report Q3 Earnings: Here's What to Expect - MSN
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine - Yahoo! Voices
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):